Shandong Cinda Biochemical Co
Because these compounds stimulate natural growth hormone activity rather than replacing growth hormone directly, they are often viewed as a more physiologic approach to hormonal support
Zhang N, Zhang L, Li Y, Gordon ML , Cai L, Wang Y, Xing M, Cheng Y
Reference: Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial by Rohit Loomba, Erin Morgan, Keyvan Yousefi, Dan Li, Richard Geary, Sanjay Bhanot and Naim Alkhouri, 23 August 2025, The Lancet
Both options are prescribed by licensed U.S
That's not luck - that's precision formulation meeting patient need